Pharma and Biotech Financial Outlook

The downturn in the global economy has forced Pharmaceutical and life sciences companies to focus on cost-saving initiatives, putting stress on finance departments. Although optimizing costs will always be important, reinvigorating R&D will most likely be a top strategic initiative for these companies as well. Most big Pharmaceutical companies are under competitive pressure from generic drug makers pressure that will become more intense as an increasing number of patents for “blockbuster” drugs expire during the next few years.


    Related Conference of Pharma and Biotech Financial Outlook

    December 05-06, 2023

    2nd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    February 01-02, 2024

    37th World Congress on Pharmacology

    Dubai, UAE
    February 22-23, 2024

    34th Annual European Pharma Congress

    Zurich, Switzerland
    April 04-05, 2024

    17th European Biosimilars Congress

    Madrid, Spain
    April 11-12, 2024

    5th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    May 09-10, 2024

    4th Global Summit on Pharmaceutical Research

    Barcelona, Spain
    May 16-17, 2024

    18th World Drug Delivery Summit

    Rome, Italy
    May 30-31, 2024

    9th Pharmaceutical Chemistry Conference

    Paris, France
    September 11-12, 2024

    9th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 25-26, 2024

    4th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Pharma and Biotech Financial Outlook Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in